Request Trial
29 May 2025NewsAmericasRavi Srinivasan, JA Kemp

WATCH: Evergreening (or life cycle management patents—including polymorphs and patents arising from clinical trial data

Ravi Srinivasan of JA Kemp explores strategies for identifying, prosecuting, and defending follow-on patent applications after a therapeutic product enters the public domain. The session at LSPN covers patents based on clinical trial data and polymorphs of small molecule drugs.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
AbbVie’s trade secret suit against a Chinese rival gets green light
18 May 2026   A US court has refused to throw out AbbVie's claim that a former scientist brought its cancer drug secrets to a Chinese rival.
Americas
WATCH: Kymera Therapeutics’ Sylvia Yip on in-house leadership
18 May 2026   LSIPR’s senior reporter Marisa Woutersen speaks with the director of IP at Kymera Therapeutics about the realities of in-house IP leadership and the growing challenge of “fast followers” in biotech.
Americas
UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
14 May 2026   Isomorphic Labs said the funding round, led by venture firm Thrive Capital, would be used to further its drug design engine and support hiring targets.


Editor's picks

UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
Americas
UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
14 May 2026

Editor's picks

Americas
UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
14 May 2026
Americas
Penile implant maker’s $17m trade secret award unravels
20 April 2026
Biotechnology
Closing the women's health gap offers ‘benefits for all’
7 April 2026
Europe
European patent offices raise fees
2 April 2026
Americas
Argentina’s patent reset: Why pharma can no longer ignore Latin America's second-largest market
1 April 2026
Europe
WIPR debuts Global In-House Elite 2026
26 March 2026

More features

AbbVie’s trade secret suit against a Chinese rival gets green light
WATCH: Kymera Therapeutics’ Sylvia Yip on in-house leadership
UK govt backs DeepMind spinout’s $2.1bn plan to ‘solve all disease’ with AI
Blank Rome adds to growing team with patent agent from MBHB
BMS signs $15.2bn deal with China’s top pharma company
Medtech company sues over seven patents for incontinence products
10x Genomics settles suit with rival and targets DNA sequencing startup
Trade secrets, AI and the new scrutiny of big damages awards